TIME has arrived on the Making of a Breast Cancer VaccineThe Ocotober 2022 issue of TIME Magazine has published an article entitled "The Race to Make a Vaccine for Breast Cancer" spotlights the increased activity in the development of a cancer vaccine for breast cancer. The article describes what ONCY already knows in that the combination of a oncolytic virus/vaccine with an immune checkpoint inhibitor can significantly improve overall treatment outcomes for patients on this I/O combination therapy.
We also know that ONCY's IMMUNE MOLECULE PLATFORM TECHNOLOGY in pelareorep is in advanced Phase 2 clinical testing with the Bracelet-1 breast cancer trial now completed with the trial data now before both Merck KGaA and Pfizer for review and decisions on their first mover advantage.